Grigorios Siokas, Chief Executive Officer, 10% Owner at Cosmos Health Inc. (COSM), bought 218,447 shares at $0.21 ($45K) on 2026-06-11, disclosed to the SEC on 2026-06-12.
CEO Grigorios Siokas purchased 218,447 shares at $0.21 on June 11, signaling confidence in the company's long-term strategy despite the stock's steep decline. This buyback near the 52-week low suggests the CEO views the current valuation as attractive following a 97.86% drop over the past year.
The stock has plummeted 97.86% over the past year and is down 18.73% in the last five days, currently trading just 4.28% above its 52-week low of $0.1964.
Catalysts include the June 1, 2026 launch of the animal health market with the C-Scrub brand and the June 25, 2025 entry into the U.S. market via a DolCas Biotech agreement. Additionally, the company secured a $300M financing facility on Aug 7, 2025, to support its Ethereum digital asset treasury reserve strategy.
The stock exhibits extreme volatility with a beta of 4.117 and carries a short interest of 1.98% of the float, which could exacerbate price swings.
Something here stands out, but not much.
| Filing → |
| COSM | BUY | 2026-06-12 | $160K | — | Filing → |
| COSM | BUY | 2026-02-13 | $144K | — | Filing → |
| COSM | BUY | 2026-02-12 | $119K | — | Filing → |